Lombard Medical (OTCMKTS: EVARF) is one of 67 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its peers? We will compare Lombard Medical to similar businesses based on the strength of its institutional ownership, profitability, risk, earnings, analyst recommendations, valuation and dividends.
This table compares Lombard Medical and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Lombard Medical Competitors||-129.18%||-39.07%||-10.70%|
This table compares Lombard Medical and its peers top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Lombard Medical||$12.17 million||-$31.03 million||-0.07|
|Lombard Medical Competitors||$1.01 billion||$134.68 million||233.14|
Lombard Medical’s peers have higher revenue and earnings than Lombard Medical. Lombard Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
39.9% of Lombard Medical shares are owned by institutional investors. Comparatively, 66.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 11.8% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
This is a breakdown of current ratings and price targets for Lombard Medical and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Lombard Medical Competitors||199||1155||2497||85||2.63|
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.47%. Given Lombard Medical’s peers higher possible upside, analysts plainly believe Lombard Medical has less favorable growth aspects than its peers.
Risk & Volatility
Lombard Medical has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Lombard Medical’s peers have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.
Lombard Medical peers beat Lombard Medical on 6 of the 9 factors compared.
Lombard Medical Company Profile
Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.
Receive News & Ratings for Lombard Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lombard Medical and related companies with MarketBeat.com's FREE daily email newsletter.